FARN 2020 / 214 Sep 2020 14:35
Personally, I think Covid has given FARN an opportunity to progress Traumakin quicker and far cheaper than ever expected. News will come in time, but FARN are still in the WHO trials and that has to be a positive.
FARN isn't a one product company either, hence another reason for me to invest .
I will await the CEO deliver significant shareholder value, which, is it not due in the next few months?
GLA